FDA UNTITLED_LETTER - Maplerose Enterprises - August 18, 2020

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Maplerose Enterprises

Record Details

This UNTITLED LETTER record concerns Maplerose Enterprises, with an inspection on August 18, 2020, covering drugs.

Company: Maplerose Enterprises
Inspection Date: August 18, 2020
Product Type: Drugs
Person: Steven E. Porter (Program Division Director)

Open in Dashboard

ID · 9f20f8bd-a8b4-47e8-92da-36972ad701d4

Violation Codes10

21 CFR 21021 CFR 21121 U.S.C. 351(a)(2)(B)21 U.S.C. 355(a)21 U.S.C. 352(f)(1)21 U.S.C. 331(k)21 CFR 211.5821 U.S.C. 353a21 CFR 211.42(c)(10)(v)21 CFR 201.115

Full citation text and observation details available on the Dashboard.